| Title | Date | PubMed ID |
|---|
| An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors. | 2017 May 26 | 28407565 |
| Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity. | 2017 Mar 8 | 28282886 |
| Molecular characterization and functional analysis of pteridine reductase in wild-type and antimony-resistant Leishmania lines. | 2016 Jan | 26689884 |
| Structure-based design and synthesis of antiparasitic pyrrolopyrimidines targeting pteridine reductase 1. | 2014 Aug 14 | 25007262 |
| Leishmania donovani pteridine reductase 1: comparative protein modeling and protein-ligand interaction studies of the leishmanicidal constituents isolated from the fruits of Piper longum. | 2012 Dec | 22752544 |
| Dissecting the metabolic roles of pteridine reductase 1 in Trypanosoma brucei and Leishmania major. | 2011 Mar 25 | 21239486 |
| Design, synthesis and biological evaluation of novel inhibitors of Trypanosoma brucei pteridine reductase 1. | 2011 Feb 7 | 21275054 |
| Structure of recombinant Leishmania donovani pteridine reductase reveals a disordered active site. | 2011 Jan 1 | 21206018 |
| Trypanosoma brucei pteridine reductase 1 is essential for survival in vitro and for virulence in mice. | 2010 Aug | 20545846 |
| Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani. | 2010 Aug | 20519355 |